CLARANOVA SE (CLA.PA) Fundamental Analysis & Valuation

EPA:CLA • FR0013426004

Current stock price

1.07 EUR
+0.02 (+1.9%)
Last:

This CLA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLA.PA Profitability Analysis

1.1 Basic Checks

  • CLA had positive earnings in the past year.
  • CLA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
  • In the past 5 years CLA always reported a positive cash flow from operatings.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • With an excellent Return On Assets value of 54.15%, CLA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • With an excellent Return On Equity value of 179.32%, CLA belongs to the best of the industry, outperforming 99.15% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 16.07%, CLA belongs to the best of the industry, outperforming 86.32% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CLA is above the industry average of 13.21%.
Industry RankSector Rank
ROA 54.15%
ROE 179.32%
ROIC 16.07%
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • With an excellent Profit Margin value of 25.09%, CLA belongs to the best of the industry, outperforming 82.91% of the companies in the same industry.
  • CLA's Profit Margin has improved in the last couple of years.
  • CLA's Operating Margin of 6.64% is in line compared to the rest of the industry. CLA outperforms 56.41% of its industry peers.
  • CLA's Operating Margin has improved in the last couple of years.
  • CLA's Gross Margin of 80.16% is fine compared to the rest of the industry. CLA outperforms 68.38% of its industry peers.
  • CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.64%
PM (TTM) 25.09%
GM 80.16%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CLA.PA Health Analysis

2.1 Basic Checks

  • CLA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, CLA has more shares outstanding
  • Compared to 5 years ago, CLA has more shares outstanding
  • Compared to 1 year ago, CLA has an improved debt to assets ratio.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • CLA has an Altman-Z score of 1.15. This is a bad value and indicates that CLA is not financially healthy and even has some risk of bankruptcy.
  • CLA has a worse Altman-Z score (1.15) than 67.52% of its industry peers.
  • The Debt to FCF ratio of CLA is 2.40, which is a good value as it means it would take CLA, 2.40 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.40, CLA is in line with its industry, outperforming 54.70% of the companies in the same industry.
  • CLA has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CLA (1.10) is worse than 82.05% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CLA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 2.4
Altman-Z 1.15
ROIC/WACC2.01
WACC7.98%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • CLA has a Current Ratio of 0.83. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CLA (0.83) is worse than 83.76% of its industry peers.
  • A Quick Ratio of 0.80 indicates that CLA may have some problems paying its short term obligations.
  • CLA has a worse Quick ratio (0.80) than 86.32% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.8
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CLA.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 706.69% over the past year.
  • CLA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 152.38% yearly.
  • Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -2.36% in the last year.
  • Measured over the past years, CLA shows a very negative growth in Revenue. The Revenue has been decreasing by -22.02% on average per year.
EPS 1Y (TTM)706.69%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%566.67%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.92% on average over the next years.
  • CLA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -37.74% yearly.
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

Find the best growth stocksShow best growing peers

8

4. CLA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • CLA is valuated cheaply with a Price/Earnings ratio of 0.83.
  • Based on the Price/Earnings ratio, CLA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of CLA to the average of the S&P500 Index (27.87), we can say CLA is valued rather cheaply.
  • The Price/Forward Earnings ratio is 7.57, which indicates a rather cheap valuation of CLA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 94.87% of the companies listed in the same industry.
  • CLA is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.83
Fwd PE 7.57
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CLA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLA is cheaper than 98.29% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CLA is valued cheaper than 99.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 3.21
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • The excellent profitability rating of CLA may justify a higher PE ratio.
  • A cheap valuation may be justified as CLA's earnings are expected to decrease with -3.92% in the coming years.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2Y-3.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLA.PA Dividend Analysis

5.1 Amount

  • CLA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLA.PA Fundamentals: All Metrics, Ratios and Statistics

CLARANOVA SE

EPA:CLA (2/10/2026, 7:00:00 PM)

1.07

+0.02 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11
Earnings (Next)05-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap61.21M
Revenue(TTM)293.80M
Net Income(TTM)73.70M
Analysts80
Price Target2.45 (128.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-28.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.53%
Valuation
Industry RankSector Rank
PE 0.83
Fwd PE 7.57
P/S 0.21
P/FCF 2.96
P/OCF 2.6
P/B 1.49
P/tB N/A
EV/EBITDA 3.21
EPS(TTM)1.29
EY120.56%
EPS(NY)0.14
Fwd EY13.21%
FCF(TTM)0.36
FCFY33.82%
OCF(TTM)0.41
OCFY38.39%
SpS5.14
BVpS0.72
TBVpS-0.88
PEG (NY)N/A
PEG (5Y)0.01
Graham Number4.56637 (326.76%)
Profitability
Industry RankSector Rank
ROA 54.15%
ROE 179.32%
ROCE 21.86%
ROIC 16.07%
ROICexc 20.86%
ROICexgc N/A
OM 6.64%
PM (TTM) 25.09%
GM 80.16%
FCFM 7.05%
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
ROICexc(3y)41.64%
ROICexc(5y)35.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.9%
ROCE(5y)19.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-2.71%
ROICexc growth 5Y6.36%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
F-Score8
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 2.4
Debt/EBITDA 1.93
Cap/Depr 70%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 100%
Profit Quality 28.09%
Current Ratio 0.83
Quick Ratio 0.8
Altman-Z 1.15
F-Score8
WACC7.98%
ROIC/WACC2.01
Cap/Depr(3y)69.81%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)706.69%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%566.67%
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%N/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.72%
EBIT growth 3Y-0.17%
EBIT growth 5Y12.2%
EBIT Next Year-17.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3Y14.47%
FCF growth 5Y-6.06%
OCF growth 1Y-40.81%
OCF growth 3Y13.67%
OCF growth 5Y-4.45%

CLARANOVA SE / CLA.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLARANOVA SE?

ChartMill assigns a fundamental rating of 4 / 10 to CLA.PA.


Can you provide the valuation status for CLARANOVA SE?

ChartMill assigns a valuation rating of 8 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Undervalued.


Can you provide the profitability details for CLARANOVA SE?

CLARANOVA SE (CLA.PA) has a profitability rating of 8 / 10.


What is the valuation of CLARANOVA SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CLARANOVA SE (CLA.PA) is 0.83 and the Price/Book (PB) ratio is 1.49.


What is the expected EPS growth for CLARANOVA SE (CLA.PA) stock?

The Earnings per Share (EPS) of CLARANOVA SE (CLA.PA) is expected to decline by -46.15% in the next year.